Root Robotics

Root Robotics is commercializing Root, an educational and interactive robot to teach coding to many age groups and experience levels.

Wyss Technology: Root
Harvard’s Wyss Institute launches Root Robotics, an educational startup to get anyone coding
TechRadar's 2018 CES Awards – the best tech at the show
CES 2018: The Root aims to teach kindergartners how to code

ReadCoor

ReadCoor leverages the Wyss Institute’s method for simultaneously sequencing and mapping thousands of RNAs within cells and tissues to advance development of diagnostics and discover new drug targets

Wyss Institute launches ReadCoor to commercialize 3D in situ gene sequencing technology

Emulate

Emulate leverages the Wyss Institute’s organs-on-chips technology to emulate human biology towards understanding how diseases, medicines, chemicals, and foods affect human health

Human Organs-on-Chips
Wyss Institute’s technology translation engine launches ‘Organs-on-Chips’ company
Organ-On-A-Chip Startup, Emulate, Grabs $45M to Shake Up Drug Discovery
‘Organs-on-Chips’ Technology: FDA Testing Groundbreaking Science
Emulate, Inc. Awarded Grant to Fund Use of Human Emulation System aboard the International Space Station

Opsonix

Opsonix uses the Wyss Institute’s pathogen extraction approach to develop a broad-spectrum therapy for the treatment of bloodstream infections and sepsis

Pathogen Capture Technology for Infectious Disease Therapeutics and Diagnostics
Wyss Institute launches startup to commercialize new sepsis therapy
2017 Spinoff Award

Adaptive Surface Technologies

Adaptive Surface Technologies (formerly SLIPS Technologies, Inc.) leverages the Wyss Institute’s Slippery Liquid-Infused Porous Surfaces (SLIPS) technology to create a family of materials and coatings that repel virtually all fluids and biological fouling agents in industrial, medical, and consumer applications

Wyss Institute launches ‘SLIPS’ company
SLIPS (Slippery Liquid-Infused Porous Surfaces)
Nature Outlook – Materials and engineering: Rebuilding the world
Johnson & Johnson Innovation Announces New Collaborations Advancing Ground-Breaking Biomedical Innovation Around the Globe
SLIPS Technologies Announces $8.6 Million in New Funding Round

Ultivue

Ultivue is developing innovative imaging solutions to unfold new areas of biology by leveraging the Institute’s DNA-PAINT technology. At the center of the technology is the transient binding of fluorophores to targets mediated by DNA-DNA interaction

Harvard’s Wyss Institute launches Ultivue to facilitate super-resolution microscopy
Inexpensive Super-Resolution Microscopy
Ultivue Inc. Announces Completion of its Series B Financing

MediCollector

MediCollector uses the Institute’s data acquisition algorithms to enable continuous collection of data to better characterize physiological changes and treatment in patients

Wyss software licensed for hospital bedside data collection
Preventing Infant Apnea

BIOMOD

Birthed at the Wyss Institute, BIOMOD is now an independent, international biomolecular design competition based in San Fransisco

Biomod.net

NuProbe

NuProbe utilizes DNA toehold probe systems to develop non-invasive cancer and infectious disease diagnostics

NuProbe

Soft exosuit for stroke

The Institute’s soft exosuit technology has been licensed by ReWalk Robotics, Ltd. towards further development of concepts and designs of lightweight exoskeleton system technologies for medical applications such as stroke and multiple sclerosis. Licensing opportunities are available for other soft exosuit applications.

Wyss Technology: Soft exosuit
Wyss Institute collaborates with Rewalk Robotics to develop wearable exosuit for patients with limited mobility
Post-stroke patients reach terra firma with Wyss Institute’s exosuit technology

3D printed electronic parts

Voxel8 integrates capabilities in materials science, software, and hardware to produce an additive manufacturing platform that co-prints hard, soft, and electronic materials for functional industrial parts. The company is leveraging some of the Institute’s 3D printed electronic parts.

CRISPR genome editing

Editas is leveraging Institute CRISPR technology towards genome editing for the treatment of patients with genetically defined diseases.

Broad Institute, Harvard and MIT license CRISPR-Cas9 technology to Editas Medicine for therapeutic applications

Artificial robot swarms for education and research

A collective of 1024 ‘Kilobots’ (a kilo of robots) that can be programmed to exhibit complex swarming behaviors has been licensed by K-Team Corporation, which is manufacturing and marketing the novel robot "swarm" system for use in education and research.

Wyss Technology: Artificial robot swarms
Wyss Institute Signs Licensing Agreement with K-Team Corporation

Ultraspecific nucleic acid hybridization probes for detection and counting

A new class of ultraspecific nucleic acid hybridization probes that can improve the detection of naturally occurring genetic sequences has been licensed to NanoString technologies. Licensing opportunities are available for other applications.

Minimally invasive surgical device

A specialized catheter device that can repair holes in the heart or tissue defects in other organs has been licensed by HoliStick Medical. Designed to work with sticky and flexible materials such as patches, the device incorporates mechanisms to delicately close a hole without requiring the use of sutures or rigid devices.

Startup promises minimally invasive heart repair
Fixing holes in the heart without invasive surgery

Biomaterial-based cancer immunotherapy

Novartis is developing a therapeutic, biomaterial-based, cancer vaccine that promotes anti-cancer immunity for specific targets.

Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis
Implantable cancer vaccine
Personal cancer vaccine gets their own boost
Injectable 3D vaccines could fight cancer and infectious diseases
Cross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials
First cancer vaccine to eliminate tumors in mice